“Perhaps a decade away, we may see new treatments for muscular dystrophy and cystic fibrosis. I think the challenges for these diseases. have less to do with the gene-editing technology and more to do with figuring out how to deliver the editing molecules into tissues.”— Jennifer Doudna, newsweek.comTagged: Gene Editing, Predictions, Cystic Fibrosis
“As challenging as the patenting process is, I respect the fact that it really does enable companies to have protection as they are working on commercial use of the technologies. This need is especially important for human therapies, which require a lot of financial investment and a long time to deve…”— Jennifer Doudna, newsweek.comTagged: Patent Law, Patents, Business, Long-Term Projects